Compare Stocks: ABT, GMM, GM, PFE, and QDEL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABT Abbott Laboratories	$110.02 -3.2%	$104.04	$81.97 ▼ $132.02	$190.62B	0.54	9.81 million shs	8.35 million shs
GM General Motors	$86.24 -3.5%	$83.35	$67.06 ▼ $93.70	$75.87B	1.4	8.39 million shs	9.05 million shs
GMM Global Mofy AI	$1.03 +10.6%	$1.65	$0.83 ▼ $92.50	$10.55M	-1.69	26,378 shs	29,170 shs
PFE Pfizer	$29.38 -1.7%	$28.74	$23.62 ▼ $31.44	$174.81B	0.31	30.70 million shs	48.29 million shs
QDEL QuidelOrtho	$10.70 -16.7%	$12.59	$9.92 ▼ $35.58	$962.11M	0.77	2.29 million shs	2.82 million shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABT Abbott Laboratories	-3.01%	+3.47%	+11.47%	+2.05%	-11.72%
GM General Motors	-3.31%	-1.25%	+6.44%	-1.56%	+25.46%
GMM Global Mofy AI	+10.63%	-0.96%	-40.80%	-64.85%	-98.88%
PFE Pfizer	-1.76%	-3.61%	+5.07%	+10.03%	+19.24%
QDEL QuidelOrtho	-16.67%	-19.25%	-13.08%	-12.87%	-60.91%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABT Abbott Laboratories	$110.02 -3.2%	$104.04	$81.97 ▼ $132.02	$190.62B	0.54	9.81 million shs	8.35 million shs
GM General Motors	$86.24 -3.5%	$83.35	$67.06 ▼ $93.70	$75.87B	1.4	8.39 million shs	9.05 million shs
GMM Global Mofy AI	$1.03 +10.6%	$1.65	$0.83 ▼ $92.50	$10.55M	-1.69	26,378 shs	29,170 shs
PFE Pfizer	$29.38 -1.7%	$28.74	$23.62 ▼ $31.44	$174.81B	0.31	30.70 million shs	48.29 million shs
QDEL QuidelOrtho	$10.70 -16.7%	$12.59	$9.92 ▼ $35.58	$962.11M	0.77	2.29 million shs	2.82 million shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABT Abbott Laboratories	-3.01%	+3.47%	+11.47%	+2.05%	-11.72%
GM General Motors	-3.31%	-1.25%	+6.44%	-1.56%	+25.46%
GMM Global Mofy AI	+10.63%	-0.96%	-40.80%	-64.85%	-98.88%
PFE Pfizer	-1.76%	-3.61%	+5.07%	+10.03%	+19.24%
QDEL QuidelOrtho	-16.67%	-19.25%	-13.08%	-12.87%	-60.91%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABT Abbott Laboratories	2.89	Moderate Buy	$118.32	7.54% Upside
GM General Motors	2.82	Moderate Buy	$101.44	17.63% Upside
GMM Global Mofy AI	1.00	Sell	N/A	N/A
PFE Pfizer	2.19	Hold	$30.39	3.43% Upside
QDEL QuidelOrtho	1.67	Reduce	$13.63	27.34% Upside

Current Analyst Ratings Breakdown

Latest ABT, GMM, GM, PFE, and QDEL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
11/6/2026	PFE Pfizer	FBN Securities Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$34.00
11/6/2026	PFE Pfizer	Freedom Broker Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$33.00 ➝ $34.00
11/6/2026	PFE Pfizer	DZ Bank Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Buy ➝ Hold
11/5/2026	PFE Pfizer	Guggenheim Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$31.00 ➝ $33.00
11/4/2026	PFE Pfizer	Argus Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$40.00
11/4/2026	PFE Pfizer	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Neutral	$27.00 ➝ $30.00
11/4/2026	PFE Pfizer	Scotiabank Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Sector Outperform	$33.00 ➝ $35.00
11/4/2026	PFE Pfizer	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Neutral	$27.00 ➝ $30.00
11/4/2026	PFE Pfizer	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Sector Perform	$25.00 ➝ $28.00
10/30/2026	GM General Motors	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C) ➝ Buy (B-)
10/29/2026	GMM Global Mofy AI	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D) ➝ Sell (D-)

(Data available from 11/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABT Abbott Laboratories	$44.33B	4.29	$6.98 per share	15.76	$30.35 per share	3.63
GM General Motors	$185.02B	0.39	$25.90 per share	3.33	$76.48 per share	1.13
GMM Global Mofy AI	$55.94M	0.18	N/A	N/A	$104.80 per share	0.01
PFE Pfizer	$62.58B	2.68	$4.21 per share	6.98	$15.26 per share	1.93
QDEL QuidelOrtho	$2.73B	0.27	$14.46 per share	0.74	$28.27 per share	0.38

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABT Abbott Laboratories	$6.52B	$2.68	41.05	18.55	1.93	9.75%	17.97%	9.22%	N/A
GM General Motors	$2.70B	$4.36	19.78	5.89	0.51	2.12%	19.36%	4.37%	N/A
GMM Global Mofy AI	-$19.30M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PFE Pfizer	$7.77B	$0.70	41.97	9.86	2.08	6.80%	19.63%	8.46%	N/A
QDEL QuidelOrtho	-$1.13B	-$5.41	N/A	7.38	N/A	-39.20%	4.88%	1.63%	N/A

Latest ABT, GMM, GM, PFE, and QDEL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/3/2026	Q3 2026	PFE Pfizer	$0.7350	$0.87	+$0.1350	$0.56	$15.85 billion	$16.58 billion
11/3/2026	Q3 2026	QDEL QuidelOrtho	$0.18	$0.31	+$0.13	-$0.78	$627.83 million	$618.90 million
10/21/2026	Q3 2026	ABT Abbott Laboratories	$1.42	$1.42	N/A	$0.53	$12.99 billion	$13.01 billion
10/20/2026	Q3 2026	GM General Motors	$3.69	$3.70	+$0.01	$3.73	$48.78 billion	$50.02 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABT Abbott Laboratories	$2.52	2.29%	+10.39%	94.03%	54 Years
GM General Motors	$0.72	0.83%	+8.45%	16.51%	3 Years
GMM Global Mofy AI	N/A	N/A	N/A	N/A	N/A
PFE Pfizer	$1.72	5.85%	-13.20%	245.71%	16 Years
QDEL QuidelOrtho	N/A	N/A	N/A	N/A	N/A

Latest ABT, GMM, GM, PFE, and QDEL Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
10/19/2026	GM General Motors	quarterly	$0.18	0.93%	12/4/2026	12/4/2026	12/17/2026
10/6/2026	PFE Pfizer	quarterly	$0.43	5.85%	11/6/2026	11/6/2026	12/7/2026
9/17/2026	ABT Abbott Laboratories	quarterly	$0.63	2.4%	10/15/2026	10/15/2026	11/16/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABT Abbott Laboratories	0.57	1.38	0.97
GM General Motors	1.32	1.09	0.94
GMM Global Mofy AI	N/A	1.89	N/A
PFE Pfizer	0.71	1.27	0.96
QDEL QuidelOrtho	1.43	1.39	0.76

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABT Abbott Laboratories	75.18%
GM General Motors	92.67%
GMM Global Mofy AI	2.48%
PFE Pfizer	68.36%
QDEL QuidelOrtho	99.00%

Insider Ownership

Company	Insider Ownership
ABT Abbott Laboratories	0.46%
GM General Motors	0.44%
GMM Global Mofy AI	N/A
PFE Pfizer	0.62%
QDEL QuidelOrtho	1.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABT Abbott Laboratories	115,000	1.73 billion	1.72 billion	Optionable
GM General Motors	156,000	843.55 million	839.84 million	Optionable
GMM Global Mofy AI	90	9.59 million	N/A	Not Optionable
PFE Pfizer	75,000	5.70 billion	5.66 billion	Optionable
QDEL QuidelOrtho	6,500	68.57 million	67.82 million	Optionable

ABT, GMM, GM, PFE, and QDEL Headlines

Recent News About These Companies

QuidelOrtho (NASDAQ:QDEL) Shares Break Below 50 Day Moving Average - Time to Sell?

2 hours ago | marketbeat.com

QuidelOrtho Corporation 2026 Q3 - Results - Earnings Call Presentation

November 6 at 6:12 PM | seekingalpha.com

QuidelOrtho (NASDAQ:QDEL) Stock Falls 9.2% - Time to Sell?

November 6 at 12:59 PM | marketbeat.com

QuidelOrtho Corporation (NASDAQ:QDEL) Stock Has Consensus Price Target of $13.62 According to Brokerages

November 6 at 2:28 AM | americanbankingnews.com

QuidelOrtho Corporation (QDEL) - What Are Brokerages Thinking About This Stock?

November 6 at 2:28 AM | marketbeat.com

QuidelOrtho Corporation Updates Earnings Guidance for the Full-Year 2026

November 4 at 3:45 PM | marketscreener.comM

QuidelOrtho (QDEL) Q3 2026 Earnings Call Transcript

November 4 at 3:45 PM | finance.yahoo.com

QuidelOrtho Corporation Q3 Earnings Summary

November 4 at 7:53 AM | rttnews.com

QuidelOrtho Corporation (QDEL) Q3 2026 Earnings Call Transcript

November 4 at 5:00 AM | seekingalpha.com

QuidelOrtho Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 27, 2026

November 3, 2026 | marketscreener.comM

QuidelOrtho (NASDAQ:QDEL) reports sales below analyst estimates in Q3 2026 earnings, stock drops 10.6%

November 3, 2026 | msn.com

What QuidelOrtho (QDEL) Said on Its Q3 Earnings Call

November 3, 2026 | marketbeat.com

QuidelOrtho (QDEL) Beats Q3 Earnings and Revenue Estimates

November 3, 2026 | zacks.com

QuidelOrtho Q3 2026 Earnings Call Transcript

November 3, 2026 | benzinga.com

QuidelOrtho (NASDAQ:QDEL) Releases Earnings Results

November 3, 2026 | marketbeat.com

QuidelOrtho Announces Restructuring and New Business Leadership Changes

November 3, 2026 | tipranks.com

QuidelOrtho Reports Third Quarter 2026 Financial Results

November 3, 2026 | prnewswire.com

QuidelOrtho (QDEL) vs. The Competition Financial Contrast

November 3, 2026 | americanbankingnews.com

What to expect from QuidelOrtho’s (QDEL) Q3 earnings

November 2, 2026 | msn.com

QuidelOrtho (QDEL) Expected to Post Earnings on Tuesday

November 1, 2026 | americanbankingnews.com

Transforming Data Into Actionable Insights in the Lab

October 29, 2026 | prnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ABT, GMM, GM, PFE, and QDEL Company Descriptions

Abbott Laboratories NYSE:ABT

$110.02 -3.58 (-3.15%)

Closing price 11/6/2026 03:59 PM Eastern

Extended Trading

$109.60 -0.42 (-0.38%)

As of 11/6/2026 07:59 PM Eastern

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

General Motors NYSE:GM

$86.24 -3.09 (-3.46%)

Closing price 11/6/2026 03:59 PM Eastern

Extended Trading

$86.64 +0.41 (+0.47%)

As of 11/6/2026 07:44 PM Eastern

General Motors Company designs, builds, and sells trucks, crossovers, cars, and automobile parts; and provide software-enabled services and subscriptions worldwide. The company operates through GM North America, GM International, Cruise, and GM Financial segments. It markets its vehicles primarily under the Buick, Cadillac, Chevrolet, GMC, Baojun, and Wuling brand names. In addition, the company sells trucks, crossovers, cars, and automobile parts through retail dealers, and distributors and dealers, as well as to fleet customers, including daily rental car companies, commercial fleet customers, leasing companies, and governments. Further, it offers range of after-sale services through dealer network, such as maintenance, light repairs, collision repairs, vehicle accessories, and extended service warranties. Additionally, the company provides automotive financing; and software-enabled services and subscriptions. General Motors Company was founded in 1908 and is headquartered in Detroit, Michigan.

Global Mofy AI NASDAQ:GMM

$1.03 +0.10 (+10.63%)

Closing price 11/6/2026 04:00 PM Eastern

Extended Trading

$1.02 -0.01 (-0.97%)

As of 11/6/2026 07:42 PM Eastern

Global Mofy Metaverse Limited, through its subsidiaries, provides virtual content production, digital marketing, and digital assets development services for the metaverse industry in the People's Republic of China. It offers services for visual effect design, content development, production, and integration based on customers specific needs; and 3D rebuilt and artificial intelligence technologies using its Mofy Lab technology platform. The company also grants use right of digital assets for various applications, such as movies, TV series, AR/VR, animation, advertising, and gaming. Global The company was incorporated in 2021 and is headquartered in Beijing, the People's Republic of China.

Pfizer NYSE:PFE

$29.38 -0.50 (-1.67%)

Closing price 11/6/2026 03:59 PM Eastern

Extended Trading

$29.38 -0.01 (-0.02%)

As of 11/6/2026 07:59 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

QuidelOrtho NASDAQ:QDEL

$10.70 -2.14 (-16.67%)

Closing price 11/6/2026 04:00 PM Eastern

Extended Trading

$10.85 +0.15 (+1.41%)

As of 11/6/2026 07:46 PM Eastern

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ABT, GMM, GM, PFE, and QDEL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ABT, GMM, GM, PFE, and QDEL Earnings

Compare Dividends

Latest ABT, GMM, GM, PFE, and QDEL Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ABT, GMM, GM, PFE, and QDEL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ABT, GMM, GM, PFE, and QDEL Company Descriptions

Abbott Laboratories NYSE:ABT

General Motors NYSE:GM

Global Mofy AI NASDAQ:GMM

Pfizer NYSE:PFE

QuidelOrtho NASDAQ:QDEL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools